{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T23:18:40Z","timestamp":1776381520485,"version":"3.51.2"},"reference-count":31,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: This systematic review evaluates the effectiveness of various hematological treatment protocols and local hemostatic measures in preventing oral bleeding and other complications during and after dental treatments in children with inherited bleeding disorders and inhibitors. Methods: This study was registered in the PROSPERO database. The comprehensive search strategy for this systematic review was conducted across five databases, namely, PubMed, Google Scholar, Web of Science, Scopus, and Cochrane Library. The search was aimed at identifying relevant literature published from January 2000 up to February 2024. Eligible studies included those with various designs, such as randomized controlled trials (RCTs), observational studies, cohort studies, case\u2013control studies, and cross-sectional studies. Data extraction was carried out systematically, and relevant information on study characteristics, interventions, treatment protocols, local measures, complications, and outcomes was collected. Results: The systematic review included a total of five studies, encompassing participants ranging from ages of 2 to 18 years. These studies varied in their scope, with some focusing on hemophilia A with inhibitors while others addressed broader inherited bleeding disorders. The interventions examined included various prophylactic and treatment measures such as Emicizumab, recombinant factor VIIa, and local hemostatic measures. The study outcomes primarily assessed the efficacy of these interventions in preventing postoperative bleeding and improving quality of life. Emicizumab has significantly shifted the treatment paradigm for children with inherited bleeding disorders and inhibitors. This prophylactic treatment has been associated with a marked reduction in the frequency of bleeding episodes, fewer hospital admissions for bleeding management, and enhanced participation in daily activities. Conclusions: This review highlights gaps in the management of dental care in children with inherited bleeding disorders and inhibitors. It underscores the need for standardized protocols that integrate new prophylactic treatments such as Emicizumab. Our findings suggest that adopting updated protocols can significantly reduce bleeding complications during dental procedures.<\/jats:p>","DOI":"10.3390\/jcm13247743","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T11:17:22Z","timestamp":1734520642000},"page":"7743","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Dental Considerations in Children with Inherited Bleeding Disorders and Inhibitors: A Systematic Review"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4923-2067","authenticated-orcid":false,"given":"Sanja","family":"Vujkov","sequence":"first","affiliation":[{"name":"Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2189-6769","authenticated-orcid":false,"given":"Branislav","family":"Bajkin","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Du\u0161ka","family":"Blagojevi\u0107","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isidora","family":"Ne\u0161kovi\u0107","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9516-7334","authenticated-orcid":false,"given":"Jelena","family":"Kom\u0161i\u0107","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7233-0250","authenticated-orcid":false,"given":"Ana","family":"Tadi\u0107","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3575-3921","authenticated-orcid":false,"given":"Bojan","family":"Petrovi\u0107","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,12,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hae.14046","article-title":"WFH Guidelines for the Management of Hemophilia, 3rd edition","volume":"26","author":"Srivastava","year":"2020","journal-title":"Haemophilia"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/hae.13066","article-title":"Recognizing the need for personalization of haemophilia patient-reported outcomes in the prophylaxis era","volume":"22","author":"Recht","year":"2016","journal-title":"Haemophilia"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jtha.2022.12.029","article-title":"Hemophilia treatment innovation: 50 years of progress and more to come","volume":"21","author":"Mannucci","year":"2023","journal-title":"J. Thromb. Haemost."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Banov, L., Linari, S., Ambroso, L., Ferri Grazzi, E., Gallo, S., Pasqualetti, P., and Mancuso, M.E. (2024). Better Communication for Better Management of Persons with Hemophilia: Results from a Patients\u2019-Clinicians\u2019 Project to Address the New Therapeutic Landscape. J. Clin. Med., 13.","DOI":"10.3390\/jcm13020568"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hae.12860","article-title":"Achievements, challenges and unmet needs for haemophilia patients with inhibitors: Report from a symposium in Paris, France on 20 November 2014","volume":"22","author":"Dargaud","year":"2016","journal-title":"Haemophilia"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1365-2516.2010.02231.x","article-title":"Non-genetic risk factors and the development of inhibitors in haemophilia: A comprehensive review and consensus report","volume":"16","author":"Astermark","year":"2010","journal-title":"Haemophilia"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/hae.14194","article-title":"Real-world evidence on health resource use among patients with haemophilia and inhibitor exhibiting severe bleeding episodes","volume":"27","author":"Chuansumrit","year":"2021","journal-title":"Haemophilia"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/hae.14077","article-title":"Inhibitors-Recent insights","volume":"27","author":"Pratt","year":"2021","journal-title":"Haemophilia"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/hae.13819","article-title":"Immune tolerance induction in paediatric patients with haemophilia A and inhibitors receiving emicizumab prophylaxis","volume":"25","author":"Batsuli","year":"2019","journal-title":"Haemophilia"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1703068","article-title":"Emicizumab Prophylaxis in Hemophilia A with Inhibitors","volume":"377","author":"Oldenburg","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/hae.13817","article-title":"Management of bleeding and invasive procedures in haemophilia A patients with inhibitor treated with emicizumab (Hemlibra(\u00ae)): Proposals from the French network on inherited bleeding disorders (MHEMO), the French Reference Centre on Haemophilia, in collaboration with the French Working Group on Perioperative Haemostasis (GIHP)","volume":"25","author":"Susen","year":"2019","journal-title":"Haemophilia"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1111\/hae.14880","article-title":"Efficacy, safety and cost of emicizumab prophylaxis in haemophilia A patients with inhibitors: A nationwide observational study in Taiwan","volume":"29","author":"Shen","year":"2023","journal-title":"Haemophilia"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/hae.14322","article-title":"Concomitant use of bypassing agents with emicizumab for people with haemophilia A and inhibitors undergoing surgery","volume":"27","author":"Matsushita","year":"2021","journal-title":"Haemophilia"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/adj.12813","article-title":"Inherited bleeding disorders in oral procedures. Assessment of prophylactic and therapeutic protocols: A scoping review","volume":"66","year":"2021","journal-title":"Aust. Dent. J."},{"key":"ref_15","unstructured":"Brewer, A. (2008). Dental manegement of patients with inhibitors to factor VIII or factor IX. Treatment of Hemophilia, World Federation of Hemophilia (WFH)."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/hae.13928","article-title":"Current state of play regarding dental extractions in patients with haemophilia: Consensus or evidence-based practice? A review of the literature","volume":"26","author":"Bajkin","year":"2020","journal-title":"Haemophilia"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/hae.14609","article-title":"Post-procedural bleeding rate and haemostatic treatment use for dental procedures before and after the implementation of a standardized protocol for people with inherited bleeding disorders","volume":"28","author":"Champagne","year":"2022","journal-title":"Haemophilia"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.bjoms.2020.08.121","article-title":"Risk factors for post-extraction bleeding in patients with haemophilia: A retrospective cohort study","volume":"59","author":"Yagyuu","year":"2021","journal-title":"Br. J. Oral Maxillofac. Surg."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2516.2005.01051.x","article-title":"Management of oral bleedings with recombinant factor VIIa in children with haemophilia A and inhibitor","volume":"11","author":"Laguna","year":"2005","journal-title":"Haemophilia"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1182\/blood.2019001869","article-title":"A multicenter, open-label phase 3 study of emicizumab prophylaxis in children with hemophilia A with inhibitors","volume":"134","author":"Young","year":"2019","journal-title":"Blood"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/hae.14005","article-title":"Real-world use of emicizumab in patients with haemophilia A: Bleeding outcomes and surgical procedures","volume":"26","author":"McCary","year":"2020","journal-title":"Haemophilia"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"520.e4","DOI":"10.1111\/hae.14266","article-title":"Inhibitor development in patients with type 3 Von Willebrand disease, a comprehensive study on 99 Iranian patients","volume":"27","author":"Jazebi","year":"2021","journal-title":"Haemophilia"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/hae.13877","article-title":"Emicizumab prophylaxis in patients with haemophilia A with and without inhibitors","volume":"26","author":"Ebbert","year":"2020","journal-title":"Haemophilia"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"6140","DOI":"10.1182\/bloodadvances.2022007458","article-title":"Surgical outcomes in people with hemophilia A taking emicizumab prophylaxis: Experience from the HAVEN 1-4 studies","volume":"6","author":"Peyvandi","year":"2022","journal-title":"Blood Adv."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e465","DOI":"10.1111\/hae.13035","article-title":"Activated prothrombin complex concentrate in combination with tranexamic acid: A single centre experience for the treatment of mucosal bleeding and dental extraction in haemophilia patients with inhibitors","volume":"22","author":"Windyga","year":"2016","journal-title":"Haemophilia"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Messenger, H., Kulkarni, R., Recht, M., and He, C. (2023). A Retrospective Analysis of the American Thrombosis and Hemostasis Network Dataset Describing Outcomes of Dental Extractions in Persons with Hemophilia. J. Clin. Med., 12.","DOI":"10.3390\/jcm12051839"},{"key":"ref_27","first-page":"Cd011385","article-title":"Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions","volume":"4","author":"Engelen","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/hae.12573","article-title":"Oral surgery-associated postoperative bleeding in haemophilia patients\u2014A tertiary centre\u2019s two decade experience","volume":"21","author":"Givol","year":"2015","journal-title":"Haemophilia"},{"key":"ref_29","first-page":"592","article-title":"Dental extractions on a patient with severe haemophilia A and inhibitors taking emicizumab prophylaxis","volume":"15","author":"Hamid","year":"2022","journal-title":"Case Rep. Rev. Oral Surg."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Sipos, K., M\u00e1rton, I., M\u00f3r\u00e9, M., Nagy, A.C., and Kiss, C. (2024). Assessing the factors affecting the accessibility of primary dental care for people with haemophilia. Haemophilia, 1\u20139.","DOI":"10.1111\/hae.15124"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"95","DOI":"10.36469\/jheor.2024.123374","article-title":"Patient Experience of Living with Hemophilia A: A Conceptual Model of Humanistic and Symptomatic Experience in Adolescents, Adults, and Children","volume":"11","author":"Hakimi","year":"2024","journal-title":"J. Health Econ. Outcomes Res."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/24\/7743\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:55:05Z","timestamp":1760115305000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/24\/7743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,18]]},"references-count":31,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["jcm13247743"],"URL":"https:\/\/doi.org\/10.3390\/jcm13247743","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,18]]}}}